Clinically, yellow fever is characterised by jaundice, fever, chills, headache, gastrointestinal haemorrhage(s), and ALBUMINURIA. The incubation period is 3–6 (up to 10) days. Differentiation from viral hepatitides, other viral haemorrhagic fevers, severe Plasmodium falciparum malaria, and several other infections is often impossible without sophisticated investigative techniques. Infection carries a high mortality rate. Liver histology (biopsy is contraindicated due to the haemorrhagic diathesis) shows characteristic changes; a fulminating hepatic infection is often present. Acute in?ammation of the kidneys and an in?amed, congested gastric mucosa, often accompanied by haemorrhage, are also demonstrable; myocardial involvement often occurs. Diagnosis is primarily based on virological techniques; serological tests are also of value. Yellow fever should be suspected in any travellers from an endemic area.
Management consists of instituting techniques for acute hepatocellular (liver-cell) failure. The affected individual should be kept in an isolation unit, away from mosquitoes which could transmit the disease to a healthy individual. Formerly, laboratory infections were occasionally acquired from infected blood samples. Prophylactically, a satisfactory attenuated VACCINE (17D) has been available for around 60 years; this is given subcutaneously and provides an individual with excellent protection for ten years; international certi?cates are valid for this length of time. Every traveller to an endemic area should be immunised; this is mandatory for entry to countries where the infection is endemic.... yellow fever
Both HIV-1 and HIV-2 are predominantly sexually transmitted and both are associated with secondary opportunistic infections. However, HIV-2 seems to result in slower damage to the immune system. HIV-1 is known to mutate rapidly and has given rise to other subtypes.
HIV is thought to have occurred in humans in the 1950s, but whether or not it infected humans from another primate species is uncertain. It became widespread in the 1970s but its latency in causing symptoms meant that the epidemic was not noticed until the following decade. Although it is a sexually transmitted disease, it can also be transmitted by intravenous drug use (through sharing an infected needle), blood transfusions with infected blood (hence the importance of e?ective national blood-screening programmes), organ donation, and occupationally (see health-care workers, below). Babies born of HIV-positive mothers can be infected before or during birth, or through breast feeding.
Although HIV is most likely to occur in blood, semen or vaginal ?uid, it has been found in saliva and tears (but not sweat); however, there is no evidence that the virus can be transmitted from these two body ?uids. There is also no evidence that HIV can be transmitted by biting insects (such as mosquitoes). HIV does not survive well in the environment and is rapidly destroyed through drying.
Prevalence At the end of 2003 an estimated 42 million people globally were infected with HIV – up from 40 million two years earlier. About one-third of those with HIV/AIDS are aged 15–24 and most are unaware that they are carrying the virus. During 2003 it is estimated that 5 million adults and children worldwide were newly infected with HIV, and that 3 million adults and children died. In Africa in 2003,
3.4 million people were newly infected and 2.3 million died, with more than 28 million carrying the virus. HIV/AIDS was the leading cause of death in sub-Saharan Africa where over half of the infections were in women and 90 per cent of cases resulted from heterosexual sex. In some southern African countries, one in three pregnant women had HIV.
In Asia and the Paci?c there were 1.2 million new infections and 435,000 deaths. The area with the fastest-growing epidemic is Eastern Europe, especially the Russian Federation where in 2002 around a million people had HIV and there were an estimated 250,000 new infections, with intravenous drug use a key contributor to this ?gure. Seventy-?ve per cent of cases occurred in men, with male-to-male sexual transmission an important cause of infection, though heterosexual activity is a rising cause of infection.
At the end of 2002 the UK had an estimated 55,900 HIV-infected adults aged between 15 and 59. More than 3,600 individuals were newly diagnosed with the infection in 2000, the highest annual ?gure since the epidemic started
– in 1998 the ?gure was 2,817 and in 1999 just over 3,000 (Department of Health and Communicable Disease Surveillance Centre). The incidence of AIDS in the UK has declined sharply since the introduction of highly active antiretroviral therapy (HAART) and HIV-related deaths have also fallen: in 2002 there were 777 reported new AIDS cases and 395 deaths, compared with 1,769 and 1,719 respectively in 1995. (Sources: UNAIDS and WHO, AIDS Epidemic Update, December 2001; Public Health Laboratory Services AIDS and STD Centre Communicable Disease Surveillance and Scottish Centre for Infection and Environmental Health, Quarterly Surveillance Tables.)
Poverty is strongly linked to the spread of AIDS, for various reasons including lack of health education; lack of e?ective public-health awareness; women having little control over sexual behaviour and contraception; and, by comparison with the developed world, little or no access to antiretroviral drugs.
Pathogenesis The cellular target of HIV infection is a subset of white blood cells called T-lymphocytes (see LYMPHOCYTE) which carry the CD4 surface receptor. These so-called ‘helper T-cells’ are vital to the function of cell-mediated immunity. Infection of these cells leads to their destruction (HIV replicates at an enormous rate – 109) and over the course of several years the body is unable to generate suf?cient new cells to keep pace. This leads to progressive destruction of the body’s immune capabilities, evidenced clinically by the development of opportunistic infection and unusual tumours.
Monitoring of clinical progression It is possible to measure the number of viral particles present in the plasma. This gives an accurate guide to the likely progression rate, which will be slow in those individuals with fewer than 10,000 particles per ml of plasma but progressively more rapid above this ?gure. The main clinical monitoring of the immune system is through the numbers of CD4 lymphocytes in the blood. The normal count is around 850 cells per ml and, without treatment, eventual progression to AIDS is likely in those individuals whose CD4 count falls below 500 per ml. Opportunistic infections occur most frequently when the count falls below 200 per ml: most such infections are treatable, and death is only likely when the CD4 count falls below 50 cells per ml when infection is developed with organisms that are di?cult to treat because of their low intrinsic virulence.
Simple, cheap and highly accurate tests are available to detect HIV antibodies in the serum. These normally occur within three months of infection and remain the cornerstone of the diagnosis.
Clinical features Most infected individuals have a viral illness some three weeks after contact with HIV. The clinical features are often non-speci?c and remain undiagnosed but include a ?ne red rash, large lymph nodes, an in?uenza-like illness, cerebral involvement and sometimes the development of opportunistic infections. The antibody test may be negative at this stage but there are usually high levels of virus particles in the blood. The antibody test is virtually always positive within three months of infection. HIV infection is often subsequently asymptomatic for a period of ten years or more, although in most patients progressive immune destruction is occurring during this time and a variety of minor opportunistic infections such as HERPES ZOSTER or oral thrush (see CANDIDA) do occur. In addition, generalised LYMPHADENOPATHY is present in a third of patients and some suffer from severe malaise, weight loss, night sweats, mild fever, ANAEMIA or easy bruising due to THROMBOCYTOPENIA.
The presentation of opportunistic infection is highly variable but usually involves either the CENTRAL NERVOUS SYSTEM, the gastrointestinal tract or the LUNGS. Patients may present with a sudden onset of a neurological de?cit or EPILEPSY due to a sudden onset of a STROKE-like syndrome, or epilepsy due to a space-occupying lesion in the brain – most commonly TOXOPLASMOSIS. In late disease, HIV infection of the central nervous system itself may produce progressive memory loss, impaired concentration and mental slowness called AIDS DEMENTIA. A wide variety of opportunistic PROTOZOA or viruses produces DYSPHAGIA, DIARRHOEA and wasting. In the respiratory system the commonest opportunistic infection associated with AIDS, pneumonia, produces severe shortness of breath and sometimes CYANOSIS, usually with a striking lack of clinical signs in the chest.
In very late HIV infection, when the CD4 count has fallen below 50 cells per ml, infection with CYTOMEGALOVIRUS may produce progressive retinal necrosis (see EYE, DISORDERS OF) which will lead to blindness if untreated, as well as a variety of gastrointestinal symptoms. At this stage, infection with atypical mycobacteria is also common, producing severe anaemia, wasting and fevers. The commonest tumour associated with HIV is Kaposi’s sarcoma which produces purplish skin lesions. This and nonHodgkin’s lymphoma (see LYMPHOMA), which is a hundred times more frequent among HIV-positive individuals than in the general population, are likely to be associated with or caused by opportunistic viral infections.
Prevention There is, as yet, no vaccine to prevent HIV infection. Vaccine development has been hampered
by the large number of new HIV strains generated through frequent mutation and recombination.
because HIV can be transmitted as free virus and in infected cells.
because HIV infects helper T-cells – the very cells involved in the immune response. There are, however, numerous research pro
grammes underway to develop vaccines that are either prophylactic or therapeutic. Vaccine-development strategies have included: recombinant-vector vaccines, in which a live bacterium or virus is genetically modi?ed to carry one or more of the HIV genes; subunit vaccines, consisting of small regions of the HIV genome designed to induce an immune response without infection; modi?ed live HIV, which has had its disease-promoting genes removed; and DNA vaccines – small loops of DNA (plasmids) containing viral genes – that make the host cells produce non-infectious viral proteins which, in turn, trigger an immune response and prime the immune system against future infection with real virus.
In the absence of an e?ective vaccine, preventing exposure remains the chief strategy in reducing the spread of HIV. Used properly, condoms are an extremely e?ective method of preventing exposure to HIV during sexual intercourse and remain the most important public-health approach to countering the further acceleration of the AIDS epidemic. The spermicide nonoxynol-9, which is often included with condoms, is known to kill HIV in vitro; however, its e?ectiveness in preventing HIV infection during intercourse is not known.
Public-health strategies must be focused on avoiding high-risk behaviour and, particularly in developing countries, empowering women to have more control over their lives, both economically and socially. In many of the poorer regions of the world, women are economically dependent on men and refusing sex, or insisting on condom use, even when they know their partners are HIV positive, is not a straightforward option. Poverty also forces many women into the sex industry where they are at greater risk of infection.
Cultural problems in gaining acceptance for universal condom-use by men in some developing countries suggests that other preventive strategies should also be considered. Microbicides used as vaginal sprays or ‘chemical condoms’ have the potential to give women more direct control over their exposure risk, and research is underway to develop suitable products.
Epidemiological studies suggest that male circumcision may o?er some protection against HIV infection, although more research is needed before this can be an established public-health strategy. Globally, about 70 per cent of infected men have acquired the virus through unprotected vaginal sex; in these men, infection is likely to have occurred through the penis with the mucosal epithelia of the inner surface of the foreskin and the frenulum considered the most likely sites for infection. It is suggested that in circumcised men, the glans may become keratinised and thus less likely to facilitate infection. Circumcision may also reduce the risk of lesions caused by other sexually transmitted disease.
Treatment AIDS/HIV treatment can be categorised as speci?c therapies for the individual opportunistic infections – which ultimately cause death – and highly active antiretroviral therapy (HAART) designed to reduce viral load and replication. HAART is also the most e?ective way of preventing opportunistic infections, and has had a signi?cant impact in delaying the onset of AIDS in HIV-positive individuals in developed countries.
Four classes of drugs are currently in use. Nucleoside analogues, including ZIDOVUDINE and DIDANOSINE, interfere with the activity of the unique enzyme of the retrovirus reverse transcriptase which is essential for replication. Nucleotide analogues, such as tenofovir, act in the same way but require no intracellular activation. Non-nucleoside reverse transcriptase inhibitors, such as nevirapine and EFAVIRENZ, act by a di?erent mechanism on the same enzyme. The most potent single agents against HIV are the protease inhibitors, such as lopinavir, which render a unique viral enzyme ineffective. These drugs are used in a variety of combinations in an attempt to reduce the plasma HIV viral load to below detectable limits, which is achieved in approximately 90 per cent of patients who have not previously received therapy. This usually also produces a profound rise in CD4 count. It is likely, however, that such treatments need to be lifelong – and since they are associated with toxicities, long-term adherence is di?cult. Thus the optimum time for treatment intervention remains controversial, with some clinicians believing that this should be governed by the viral load rising above 10,000 copies, and others that it should primarily be designed to prevent the development of opportunistic infections – thus, that initiation of therapy should be guided more by the CD4 count.
It should be noted that the drug regimens have been devised for infection with HIV-1; it is not known how e?ective they are at treating infection with HIV-2.
HIV and pregnancy An HIV-positive woman can transmit the virus to her fetus, with the risk of infection being particularly high during parturition; however, the risk of perinatal HIV transmission can be reduced by antiviral drug therapy. In the UK, HIV testing is available to all women as part of antenatal care. The bene?ts of antenatal HIV testing in countries where antiviral drugs are not available are questionable. An HIV-positive woman might be advised not to breast feed because of the risks of transmitting HIV via breastmilk, but there may be a greater risk associated with not breast feeding at all. Babies in many poor communities are thought to be at high risk of infectious diseases and malnutrition if they are not breast fed and may thus be at greater overall risk of death during infancy.
Counselling Con?dential counselling is an essential part of AIDS management, both in terms of supporting the psychological wellbeing of the individual and in dealing with issues such as family relations, sexual partners and implications for employment (e.g. for health-care workers). Counsellors must be particularly sensitive to culture and lifestyle issues. Counselling is essential both before an HIV test is taken and when the results are revealed.
Health-care workers Health-care workers may be at risk of occupational exposure to HIV, either through undertaking invasive procedures or through accidental exposure to infected blood from a contaminated needle (needlestick injury). Needlestick injuries are frequent in health care – as many as 600,000 to 800,000 are thought to occur annually in the United States. Transmission is much more likely where the worker has been exposed to HIV through a needlestick injury or deep cut with a contaminated instrument than through exposure of mucous membranes to contaminated blood or body ?uids. However, even where exposure occurs through a needlestick injury, the risk of seroconversion is much lower than with a similar exposure to hepatitis C or hepatitis B. A percutaneous exposure to HIV-infected blood in a health-care setting is thought to carry a risk of about one infection per 300 injuries (one in 1,000 for mucous-membrane exposure), compared with one in 30 for hepatitis C, and one in three for hepatitis B (when the source patient is e-antigen positive).
In the event of an injury, health-care workers are advised to report the incident immediately where, depending on a risk assessment, they may be o?ered post-exposure prophylaxis (PEP). They should also wash the contaminated area with soap and water (but without scrubbing) and, if appropriate, encourage bleeding at the site of injury. PEP, using a combination of antiretroviral drugs (in a similar regimen to HAART – see above), is thought to greatly reduce the chances of seroconversion; it should be commenced as soon as possible, preferably within one or two hours of the injury. Although PEP is available, safe systems of work are considered to o?er the greatest protection. Double-gloving (latex gloves remove much of the blood from the surface of the needle during a needlestick), correct use of sharps containers (for used needles and instruments), avoiding the resheathing of used needles, reduction in the number of blood samples taken from a patient, safer-needle devices (such as needles that self-blunt after use) and needleless drug administration are all thought to reduce the risk of exposure to HIV and other blood-borne viruses. Although there have been numerous cases of health-care workers developing HIV through occupational exposure, there is little evidence of health-care workers passing HIV to their patients through normal medical procedures.... aids/hiv
Dengue haemorrhagic fever This is a more severe form of the disease which usually occurs in young children; it is largely con?ned to the indigenous population(s) of south-east Asia. It is accompanied by signi?cant complications and mortality. Immunological status of the host is considered important in pathogenesis.... dengue
Filarial elephantiasis Wuchereria bancrofti and Brugia malayi are conveyed to humans by a mosquito bite. Resultant lymphatic obstruction gives rise to enlargement and dis?guration, with thickening of the skin (resembling that of an elephant) in one or both lower limbs and occasionally genitalia (involving particularly the SCROTUM). By the time the condition is recognised, lymphatic damage is irreversible. However, if evidence of continuing activity exists, a course of diethylcarbamazine should be administered (see FILARIASIS). Relief can be obtained by using elastic bandaging, massage, rest, and elevation of the affected limb. Surgery is sometimes indicated. For prevention, destruction of mosquitoes is important.... elephantiasis
– there may be epidemics spread by the bite of mosquitoes or ticks.
The clinical features begin with in?uenza-like symptoms – aches, temperature and wretchedness; then the patient develops a headache with drowsiness, confusion and neck sti?ness. Severely ill patients develop changes in behaviour, abnormalities of speech, and deterioration, sometimes with epileptic seizures. Some develop paralysis and memory loss. CT (see COMPUTED TOMOGRAPHY) and MRI brain scans show brain swelling, and damage to the temporal lobes if the herpes virus is involved. ELECTROENCEPHALOGRAPHY (EEG), which records the brainwaves, is abnormal. Diagnosis is possible by an examination of the blood or other body ?uids for antibody reaction to the virus, and modern laboratory techniques are very speci?c.
In general, drugs are not e?ective against viruses – antibiotics are of no use. Herpes encephalitis does respond to treatment with the antiviral agent, aciclovir. Treatment is supportive: patients should be given painkillers, and ?uid replacement drugs to reduce brain swelling and counter epilepsy if it occurs. Fortunately, most sufferers from encephalitis make a complete recovery, but some are left severely disabled with physical defects, personality and memory disturbance, and epileptic ?ts. Rabies is always fatal and the changes found in patients with AIDS are almost always progressive. Except in very speci?c circumstances, it is not possible to be immunised against encephalitis.
Encephalitis lethargica is one, now rare, variety that reached epidemic levels after World War I. It was characterised by drowsiness and headache leading on to COMA. The disease occasionally occurs as a complication after mumps and sometimes affected individuals subsequently develop postencephalitic PARKINSONISM.... encephalitis
The skin is an important protection against micro-organisms entering the body tissues. A large measure of protection is a?orded by the factors which ensure IMMUNITY against diseases.
Modes of infection The infective material may be transmitted to the person by direct contact with a sick person, when the disease is said to be contagious, although such a distinction is purely arti?cial. Di?erent diseases are especially infectious at di?erent periods of their course. Protecting people can be di?cult, since some diseases are infectious before the patient shows any symptoms (see INCUBATION).
Infection may be conveyed on dust, in drinking-water, in food (particularly milk), in the body’s waste products and secretions, or even on clothes and linen which have been in contact with the infected individual (called fomites).
Some people who have recovered from a disease, or who have simply been in contact with an infectious case, harbour the infectious agent. This is particularly the case in typhoid fever (see ENTERIC FEVER), the bacillus continuing to develop in the gall-bladder of some people who have had the disease for years after the symptoms have disappeared. In the case of CHOLERA, which is ENDEMIC in some developing countries with hot climates, 80 per cent or more of the population may harbour the bacillus and spread infection when other circumstances favour this. Similarly in the case of DYSENTERY, people who have completely recovered may still be capable of infecting dust and drinking-water by their stools. DIPHTHERIA and meningococcal MENINGITIS, which is particularly liable to infect children, are other examples.
Flies can infect milk and other food with the organisms causing typhoid fever and food poisoning. Mosquitoes carry the infective agents of MALARIA, DENGUE and YELLOW FEVER, these undergoing part of their development in the body of the mosquito. Fleas convey the germ of plague from rats to humans, and lice are responsible for inoculating TYPHUS FEVER and one form of RELAPSING FEVER by their bite. A tick is responsible for spreading another form of relapsing fever, and kala-azar (LEISHMANIASIS) is spread by the bites of sand?ies.
Noti?able diseases Certain of the common and most serious infectious diseases are noti?able in the United Kingdom. A doctor diagnosing someone infected by a noti?able disease must inform the authorities. For the current list of noti?able infectious diseases in the UK, see the main entry for NOTIFIABLE DISEASES.
Prevention is an important aspect of the control of infectious diseases, and various steps can be taken to check the spread of such infections as dysentery, tuberculosis, malaria and others. (See also IMMUNITY; INCUBATION.)... infection
Habitat: Not common as a wild plant, except on damp heaths and commons. Frequently seen in cottage gardens. Indigenous to Britain and Europe.
Features ? This member of the mint family grows up to twelve inches high, the stembeing bluntly quadrangular. The one to one and a half inch long, egg-shaped leaves are opposite, on short stalks ; they are slightly serrate and nearly smooth. Purple flowers appear in August. The odour is rather pungent, mint-like but characteristic.Part used ? The whole herb.Action: Carminative, emmenagogue, diaphoretic and stimulant.
An infusion of 1 ounce to 1 pint of boiling water, taken warm in teacupful doses frequently repeated, is helpful in hysteria, flatulence and sickness. For children's ailments such as feverish colds, disordered stomach and measles, Pennyroyal infusion may be given in appropriate doses with confidence. Its diaphoretic and stimulant action recommends it for chills and incipient fevers, and the infusion works as an emmenagogue when such ailments retard and obstruct menstruation. The oil of Pennyroyal is a first-rate protection against the bites of mosquitoes, gnats, and similar winged pests. The herb is used to some extent as a flavouring. Although not so popular as other herbs for this purpose, the mint-like flavour and carminative virtues of Pennyroyal should recommend it to cooks as adding to both palatability and digestibility of various dishes.American or Mock Pennyroyal are the names given to the dried leaves and flowering tops of Hedeoma pulegioides. This plant, although quite different in appearance from the European Pennyroyal, has similar medicinal values.... pennyroyalLeaves used by natives of West Africa for malaria. ... cashew tree fruit
Popular Indian: 2-3 drops oil Citronella on handkerchief and dabbed behind ears, on neck, hair, etc. Garlic repels all insects and beetles. Cedarwood essential oil kills houseflies, mosquitoes and cockroaches in concentrations of less than 1 per cent. (Central Institute for Medicinal Plants, Lucknow) ... insect repellents
Action. Many bacteria cannot live in the presence of honey since honey draws from them the moisture essential to their existence. It is a potent inhibitor of the growth of bacteria: salmonella, shigella and E. coli. Taken internally and externally, hastens granulation and arrests necrotic tissue. A natural bacteriostatic and bactericide.
Of an alkaline action, honey assists digestion, decreasing acidity. It has been used with success for burns, frostbite, colic, dry cough, inflammations, involuntary twitching of eyes and mouth; to keep a singer’s throat in condition. Some cases of tuberculosis have found it a life-preserver.
A cooling analgesic: dressings smeared with honey and left on after pain has subsided to prevent swelling – for cuts, scratches, fistula, boils, felon, animal bites; stings of mosquitoes, wasps, bees, fleas, etc. May be applied to any kind of wound: dip gauze strips in pure honey and bind infected area; leave 24 hours.
Insomnia: 2 teaspoons to glass of hot milk at bedtime.
Arterio-sclerosis: with pollen, is said to arrest thickening of the arteries.
2, 3 or more teaspoons daily to prevent colds and influenza.
2 teaspoons in water or tea for renewed vitality when tired.
Rheumatism and arthritis: 2 teaspoons honey and 2 teaspoons Cider vinegar in water 2-3 times daily.
“The taking of honey each day is advised in order to keep the lymph flowing at its normal tempo and thus avoid degenerative disease which shortens life. The real value of honey is to maintain a normal flow of the tissue fluid called lymph. When this flow-rate slows down, then calcium and iron are precipitated as sediment. When the lymph flow is stagnant, then harmful micro-organisms invade the body and sickness appears.” (D.C. Jarvis MD)
Where sweetening is required to ensure patient compliance, honey is better than sugar. Its virtues deteriorate in open sunlight. Should not be heated above 40°C. ... honey
All insect bites provoke a skin reaction to substances in the insect’s saliva or faeces, which may be deposited at or near the site of the bite. Reactions vary from red pimples to painful swellings or an intensely itching rash; some insects, such as bees and wasps, have stings (see insect stings) that can produce fatal allergies. (See also lice; spider bites; mites and disease; ticks and disease.)... insect bites
A number of serious diseases are spread by biting insects.
These include malaria and filariasis (transmitted by mosquitoes), sleeping sickness (tsetse flies), leishmaniasis (sandflies), epidemic typhus (lice), and plague (rat fleas).
Mosquitoes, sandflies, and ticks can also spread illnesses such as yellow fever, dengue, Lyme disease, and some types of viral encephalitis.
Organisms picked up when an insect ingests blood from an infected animal or person are able to survive or multiply in the insect.
Later, the organisms are either injected into a new human host via the insect’s saliva or deposited in the faeces at or near the site of the bite.
Most insect-borne diseases are confined to the tropics and subtropics, although tick-borne Lyme disease occurs in some parts of the.
The avoidance of insect-borne disease is largely a matter of keeping flies off food, discouraging insect bites by the use of suitable clothing and insect repellents, and, in parts of the world where malaria is present, the use of mosquito nets and screens, pesticides, and antimalarial tablets.... insects and disease
As well as being irritating, mosquito bites can also transmit diseases. The main disease-transmitting mosquitoes belong to 3 groups: ANOPHELES (which transmits malaria), AEDES (which carries yellow fever), and CULEX (which transmits filariasis).
Preventive measures should be taken in any area where mosquitoes are rampant. The most effective measures are wearing long sleeves and socks, placing mosquito screens over windows, and using insect-repellent sprays or slowburning coils that release insecticidal smoke. Mosquito nets should be placed over beds. (See also insect bites; insects and disease.)... mosquito bites
FAMILY: Cupressaceae
SYNONYMS: Red cedar, eastern red cedar, southern red cedar, Bedford cedarwood (oil).
GENERAL DESCRIPTION: A coniferous, slow-growing, evergreen tree up to 33 metres high with a narrow, dense and pyramidal crown, a reddish heartwood and brown cones. The tree can attain a majestic stature with a trunk diameter of over 1.5 metres.
DISTRIBUTION: Native to North America, especially mountainous regions east of the Rocky Mountains.
OTHER SPECIES: There are many cultivars of the red cedar; its European relative is the shrubby red cedar (J. sabina) also known as savin – see entry. It is also closely related to the East African cedarwood (J. procera).
HERBAL/FOLK TRADITION: The North American Indians used it for respiratory infections, especially those involving an excess of catarrh. Decoctions of leaves, bark, twigs and fruit were used to treat a variety of ailments: menstrual delay, rheumatism, arthritis, skin rashes, venereal warts, gonorrhoea, pyelitis and kidney infections.
It is an excellent insect and vermin repellent (mosquitoes, moths, woodworm, rats, etc.) and was once used with citronella as a commercial insecticide.
ACTIONS: Abortifacient, antiseborrhoeic, antiseptic (pulmonary, genito-urinary), antispasmodic, astringent, balsamic, diuretic, emmenagogue, expectorant, insecticide, sedative (nervous), stimulant (circulatory).
EXTRACTION: Essential oil by steam distillation from the timber waste, sawdust, shavings, etc. (At one time a superior oil was distilled from the red heartwood, from trees over twenty five years old.)
CHARACTERISTICS: A pale yellow or orange oily liquid with a mild, sweet-balsamic, ‘pencil wood’ scent. It blends well with sandalwood, rose, juniper, cypress, vetiver, patchouli and benzoin.
PRINCIPAL CONSTITUENTS: Mainly cedrene (up to 80 per cent), cedrol (3–14 per cent), and cedrenol, among others.
SAFETY DATA: Externally the oil is relatively non-toxic; can cause acute local irritation and possible sensitization in some individuals. Use in dilution only with care, in moderation. ‘The oil is a powerful abortifacient … use of the oil has been fatal.’. Avoid during pregnancy. Generally safer to use Atlas cedarwood.
AROMATHERAPY/HOME: USE
Skin Care: Acne, dandruff, eczema, greasy hair, insect repellent, oily skin, psoriasis.
Circulation, Muscles And Joints: Arthritis, rheumatism.
Respiratory System: Bronchitis, catarrh, congestion, coughs, sinusitis.
Genito-Urinary System: Cystitis, leucorrhoea.
Nervous System: Nervous tension and stress-related disorders.
OTHER USES: Extensively used in room sprays and household insect repellents. Employed as a fragrance component in soaps, cosmetics and perfumes. Used as the starting material for the isolation of cedrene.... cedarwood, virginian